摘要 |
The invention relates to an apolipoprotein construct, an apolipoprotein construct for use as a medicament, a nucleic acid sequence encoding the apolipoprotein construct, a vector comprising the nucleic acid sequence, a method for producing the apolipoprotein construct, and use of the apolipoprotein construct for the preparation of apharmaceutical composition. The presented data document that the constructs according to the invention a re capable of binding lipids, are capable of binding cubilin, which is a strong Apo Al receptor, stronger than native Apo A-I and that the plasma half life of the constructs is at least tripled compared to native Apo A-I. Together thes e data document that the constructs according to the invention are strong candidates for treatment of cardiovascular diseases.
|